NeoTract said today it won coverage for its Urolift system from Medicare Administrative Contractor First Coast Service Options. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the enlarged prostate. First Coast Service Options covers […]
NeoTract
NeoTract touts reimbursement win for UroLift
NeoTract today touted a reimbursement win from Geisinger Health Plan and EmblemHealth that will allow coverage for procedures using its UroLift system for patients with benign prostatic hyperplasia. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside […]
NeoTract logs reimbursement wins for UroLift prostate treatment
NeoTract said today that it logged several reimbursement wins for its UroLift treatment for enlarged prostates, including a Medicare contractor and at least 7 independent insurers. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the […]
NeoTract touts 4-year UroLift data
NeoTract today released the results from 2 randomized studies of its UroLift system designed to treat benign prostatic hyperplasia, touting “excellent” durability after 4 years. The data was presented at the American Urological Association’s 2016 annual meeting in San Diego this week. “The clinical data presented at this year’s AUA conference show that treatment with the […]
NeoTract launches MedLift trial
NeoTract said Monday it enrolled the 1st patient in its MedLift U.S. investigational device exemption trial of its UroLift system for treating patients with benign prostatic hyperplasia. The new study from Pleasanton, Calif.-based NeoTract will be conducted across 8 sites in the U.S. and will examine the safety and efficacy of the UroLift system for […]
Neotract touts UK NHS savings, better reimbursements
Neotract said today a new analysis from the U.K.’s National Institute for Health and Care Excellence reported a (UK £286) $443 savings per patient per day when using its UroLift system to treat enlarged prostates, compared to the most common surgical intervention. The NICE reported other benefits of the system, including preservation of sexual function, […]